Author： Sewerynek Ewa Stuss Michal
Publisher： Future Medicine
ISSN： 1745-509X
Source： Aging Health, Vol.8, Iss.5, 2012-10, pp. : 471-477
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Glucocorticoids are quite commonly used in the treatment of many diseases and are one of the most common causes of secondary osteoporosis. Osteoporosis associated with chronic steroid therapy, appears to be an important medical problem. In the USA, glucocorticoids are prescribed to 1 million patients a year. Data from the UK reveal as many as 1.6 million prescriptions for steroid agents within 10 years. Glucocorticoids are used by 0.9% of the total population and approximately 2.5% in the age group of 70–79 years. It is very important to develop the knowledge about osteoporosis, which accompanies chronic steroid therapy, especially with regard to effective counteraction and prevention rules, not only among primary care physicians, but also among patients.
Related content
Drug-induced osteoporosis in the older adult
By O’Connell Mary Beth Borgelt Laura M Bowles Susan K Vondracek Sheryl F
Aging Health, Vol. 6, Iss. 4, 2010-08 ,pp. :
Access to resources
Recommend
Osteoporosis in the aging population: the male perspective
By Kaufman J. M. Zmierczak H. Goemaere S.
The Aging Male, Vol. 4, Iss. 2, 2001-06 ,pp. :
Denosumab: a novel biological therapy for osteoporosis
Aging Health, Vol. 7, Iss. 1, 2011-02 ,pp. :